Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board denied the veteran's request for an effective date prior to April 23, 2020, for service connection of tinea versicolor with tinea pedis. The decision is based on the finality of previous denials and lack of new evidence.

The Board denied the veteran's claim for an initial compensable rating for seborrheic dermatitis because the evidence did not show that the condition affected at least 5 percent of the body or required systemic therapy.

The Board denied service connection for bilateral hearing loss and PTSD, as well as an increased rating for pseudofolliculitis barbae.

The Board denied service connection for several conditions but granted it for genitourinary system disability, tension headaches, left knee strain, and right knee strain. The claims for bilateral hip strain, bilateral shoulder strain, major depressive disorder with anxiety and PTSD, neurobehavior effects, insomnia, poor concentration, and bilateral lateral epicondylitis were remanded.

The Board remanded the case to obtain an adequate examination of the veteran's scarring. The current examinations were found inadequate for adjudication.

Service connection for obstructive sleep apnea is granted. Service connection for bilateral hearing loss and scrotal pain is denied. Other issues are remanded.

The veteran's claim for an earlier effective date for service connection of pseudofolliculitis barbae and compensable ratings for pseudofolliculitis barbae and bilateral hearing loss were denied. However, the veteran was granted an effective date of May 9, 2005, for a total disability rating based on individual unemployability (TDIU).

The veteran withdrew their appeals for increased ratings for fungal dermatitis and tension headaches, as well as entitlement to special monthly compensation (SMC). The Board dismissed these appeals.

The veteran's claim for service connection of skin conditions other than dermatitis was denied. The veteran was granted a 10 percent rating for dermatitis but denied higher ratings for diabetes and TDIU.

The Board has remanded the cases for further development due to a failure to comply with duty-to-assist requirements.

The Board denied the veteran's claim for a total disability rating based on individual unemployability (TDIU) prior to February 7, 2013, because the evidence showed the veteran was able to maintain full-time employment during that period.

The Board denied an initial rating in excess of 10 percent for the veteran's service-connected dermatitis, finding that the condition did not meet the criteria for a higher rating.

The Board denied a compensable rating for the veteran's chloracne because it was rated as noncompensable based on superficial acne with no scarring or disfigurement.

The veteran's service connection for a cervical spine condition and fatigue due to an undiagnosed illness was granted. The veteran's rating for unspecified anxiety disorder was restored to 70 percent. Other issues were denied or remanded.

The Board remanded the claim for an initial rating in excess of 30 percent for psoriasis to ensure a complete record and due process.

The veteran's claims for increased ratings for bilateral hearing loss, tinnitus, and pseudofolliculitis barbae were denied. The claim for restoration of the 20 percent rating for hemorrhoids was granted. Claims for cervical degenerative arthritis and left upper extremity radiculopathy were remanded.

Service connection for pseudofolliculitis barbae is granted. The claim for obstructive sleep apnea is remanded for further evaluation.

The veteran's claims for service connection for unspecified dermatitis of the hands and seborrheic dermatitis of the scalp were granted.

The Veteran's service-connected disabilities preclude him from securing or maintaining substantially gainful employment, so he is granted Total Disability based on Individual Unemployability (TDIU).

The Board denied the veteran's claims for an earlier effective date for a 100% rating for heart disabilities and for a higher rating for eczema.